GenScript Biotech Corp, a global leader in life sciences R&D and manufacturing services, today announced that it is committing to aggressive carbon emission reduction targets. These targets have been ...
USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Jin Yang-gon boosts HLB holdings with share purchases in bioStep and Innovation Chairman Jin Yang-gon increases ownership in ...
Kilroy Realty has opened a second phase of its Oyster Point life sciences campus — but it's attracting financial and tech ...
AdvanCell is developing therapies to treat cancers including: prostate, skin, pancreatic, breast, bladder, colorectal, kidney ...
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...
Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...
Biotechnology and Microbiology both deal with biological sciences, but the difference between Biotechnology and Microbiology ...
(NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs ...
A $445 million contract for technology services has been put on hold by two state senators who call it another example of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback